首页> 外国专利> SUSTAINED-RELEASE DRUG DELIVERY FORMULATION FOR TREATING MENTAL DISEASES OR CENTRAL NERVOUS SYSTEM DISEASES AND PRODUCING METHOD THEREOF

SUSTAINED-RELEASE DRUG DELIVERY FORMULATION FOR TREATING MENTAL DISEASES OR CENTRAL NERVOUS SYSTEM DISEASES AND PRODUCING METHOD THEREOF

机译:缓解精神疾病或中枢神经系统疾病的缓释药物制剂及其生产方法

摘要

The present invention relates to a sustained-release drug delivery formulation for treating mental diseases or central nervous system diseases and a method for producing the same and, more specifically, to a sustained-release drug delivery formulation for treating mental diseases or central nervous system diseases, which includes microspheres containing biodegradable polymers and drugs; and a method for producing the same. The drug delivery formulation according to the present invention, which is a sustained-release microsphere formulation capable of maintaining a constant amount of drug released into blood for a long time, solves problems caused when a patient should be administered several times at regular time intervals, and has an advantage of continuously and easily obtaining desired release behavior with one administration. In addition, the producing method of a drug delivery formulation by the present invention has an advantage of reducing production time and cost by preparing a sustained-release drug delivery formulation for about 28 days or more as a simple process compared to a conventional method.;COPYRIGHT KIPO 2020
机译:本发明涉及用于治疗精神疾病或中枢神经系统疾病的缓释药物制剂及其制备方法,更具体地说,涉及用于治疗精神疾病或中枢神经系统疾病的缓释药物制剂。 ,其中包括含有可生物降解的聚合物和药物的微球;及其制造方法。根据本发明的药物递送制剂是能够长期保持恒定释放到血液中的药物量的缓释微球制剂,解决了当应以规则的时间间隔多次给予患者时引起的问题,并且具有通过一次给药连续且容易地获得所需释放行为的优点。另外,与常规方法相比,本发明的药物递送制剂的制备方法具有如下优点:通过以简单的方法制备持续释放约28天或更长时间的缓释药物递送制剂,从而减少了生产时间和成本。版权KIPO 2020

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号